These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33643662)

  • 1. Personalised inpatient multidisciplinary rehabilitation elicits clinically relevant improvements in physical function in patients with multiple sclerosis - The Danish MS Hospitals Rehabilitation Study.
    Hvid LG; Gaemelke T; Dalgas U; Slipsager MK; Rasmussen PV; Petersen T; Nørgaard M; Skjerbaek AG; Boesen F
    Mult Scler J Exp Transl Clin; 2021; 7(1):2055217321989384. PubMed ID: 33643662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study.
    Hvid LG; Stenager E; Dalgas U
    J Neurol; 2022 Sep; 269(9):4895-4908. PubMed ID: 35482080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study.
    Cohen ET; Kietrys D; Fogerite SG; Silva M; Logan K; Barone DA; Parrott JS
    Int J MS Care; 2017; 19(1):30-39. PubMed ID: 28243184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can inpatient multidisciplinary rehabilitation improve health-related quality of life in MS patients on the long term - The Danish MS Hospitals Rehabilitation Study.
    Boesen F; Nørgaard M; Skjerbæk AG; Rasmussen PV; Petersen T; Løvendahl B; Trénel P
    Mult Scler; 2020 Dec; 26(14):1953-1957. PubMed ID: 31687884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-intensity aerobic exercise on common multiple sclerosis symptoms.
    Langeskov-Christensen M; Hvid LG; Jensen HB; Nielsen HH; Petersen T; Stenager E; Dalgas U
    Acta Neurol Scand; 2022 Feb; 145(2):229-238. PubMed ID: 34687036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subjective minimal important change for the Six Spot Step Test in people with multiple sclerosis - The Danish MS Hospitals Rehabilitation study.
    Pommerich UM; Brincks J; Skjerbæk AG; Dalgas U
    Acta Neurol Belg; 2022 Aug; 122(4):893-901. PubMed ID: 35705789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.
    Bennett SE; Bromley LE; Fisher NM; Tomita MR; Niewczyk P
    Int J MS Care; 2017; 19(5):247-252. PubMed ID: 29070965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis.
    Bertoni R; Cattaneo D; Grosso C; Baglio F; Jonsdottir J
    Mult Scler Relat Disord; 2022 Mar; 59():103683. PubMed ID: 35168094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.
    Sandroff BM; Silveira SL; Baird JF; Huynh T; Motl RW
    Phys Ther; 2021 Feb; 101(2):. PubMed ID: 33373454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.
    Salhofer-Polanyi S; Windt J; Sumper H; Grill H; Essmeister M; Diermayr G; Zebenholzer K; Leutmezer F; Zulehner G; Vass K; Asenbaum-Nan S
    NeuroRehabilitation; 2013; 33(2):285-92. PubMed ID: 23949063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
    Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
    Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
    van Munster CEP; Kaya L; Lam KH; Kalkers NF; Killestein J; Uitdehaag BMJ
    Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between fatigue impact and lifestyle factors in people with multiple sclerosis - The Danish MS hospitals rehabilitation study.
    Johansson S; Skjerbæk AG; Nørgaard M; Boesen F; Hvid LG; Dalgas U
    Mult Scler Relat Disord; 2021 May; 50():102799. PubMed ID: 33582566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation Study.
    Boesen F; Nørgaard M; Trénel P; Rasmussen PV; Petersen T; Løvendahl B; Sørensen J
    Mult Scler; 2018 Mar; 24(3):340-349. PubMed ID: 28984159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis.
    Aristotelous P; Stefanakis M; Pantzaris M; Pattichis CS; Calder PC; Patrikios IS; Sakkas GK; Giannaki CD
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.